Argen-X (ARGX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.053x

Based on the latest financial reports, Argen-X (ARGX) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€386.77 Million ≈ $452.18 Million USD) by net assets (€7.32 Billion ≈ $8.56 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Argen-X - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Argen-X's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ARGX liabilities breakdown for a breakdown of total debt and financial obligations.

Argen-X Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argen-X ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
RWE Aktiengesellschaft F:RWEA	0.095x
Entergy Corporation NYSE:ETR	0.126x
Coca-Cola European Partners PLC NASDAQ:CCEP	0.116x
American International Group Inc NYSE:AIG	0.015x
Chipotle Mexican Grill Inc NYSE:CMG	0.271x
ITC Limited NSE:ITC	0.086x
Argen-X F:1AE	N/A
Constellation Software Inc. TO:CSU	0.167x

Annual Cash Flow Conversion Efficiency for Argen-X (2011–2025)

The table below shows the annual cash flow conversion efficiency of Argen-X from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Argen-X.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€7.32 Billion ≈ $8.56 Billion	€882.43 Million ≈ $1.03 Billion	0.120x	+900.59%
2024-12-31	€5.50 Billion ≈ $6.43 Billion	€-82.75 Million ≈ $-96.74 Million	-0.015x	+85.33%
2023-12-31	€4.10 Billion ≈ $4.79 Billion	€-420.33 Million ≈ $-491.41 Million	-0.103x	+66.55%
2022-12-31	€2.81 Billion ≈ $3.29 Billion	€-862.81 Million ≈ $-1.01 Billion	-0.307x	-28.06%
2021-12-31	€2.53 Billion ≈ $2.96 Billion	€-606.81 Million ≈ $-709.43 Million	-0.239x	-0.60%
2020-12-31	€1.67 Billion ≈ $1.96 Billion	€-398.46 Million ≈ $-465.85 Million	-0.238x	-285.30%
2019-12-31	€1.18 Billion ≈ $1.38 Billion	€151.63 Million ≈ $177.27 Million	0.128x	+228.46%
2018-12-31	€615.87 Million ≈ $720.02 Million	€-61.59 Million ≈ $-72.00 Million	-0.100x	+5.62%
2017-12-31	€413.81 Million ≈ $483.79 Million	€-43.84 Million ≈ $-51.26 Million	-0.106x	-163.35%
2016-12-31	€66.65 Million ≈ $77.92 Million	€11.15 Million ≈ $13.03 Million	0.167x	+144.86%
2015-12-31	€40.76 Million ≈ $47.65 Million	€-15.19 Million ≈ $-17.76 Million	-0.373x	-256.64%
2014-12-31	€60.90 Million ≈ $71.20 Million	€-6.37 Million ≈ $-7.44 Million	-0.105x	+65.66%
2013-12-31	€29.97 Million ≈ $35.04 Million	€-9.12 Million ≈ $-10.66 Million	-0.304x	+54.29%
2012-12-31	€16.65 Million ≈ $19.47 Million	€-11.09 Million ≈ $-12.96 Million	-0.666x	-366.21%
2011-12-31	€27.90 Million ≈ $32.62 Million	€-3.98 Million ≈ $-4.66 Million	-0.143x	--

About Argen-X

BR:ARGX Belgium Biotechnology

Market Cap

$50.19 Billion

€42.93 Billion EUR

Market Cap Rank

#639 Global

#4 in Belgium

Share Price

€690.40

Change (1 day)

+0.79%

52-Week Range

€460.40 - €803.00

All Time High

€803.00